BPC-157 vs GHK-Cu

What Are BPC-157 and GHK-Cu?

BPC-157 (Body Protection Compound-157) is a Pentadecapeptide (15 amino acids). Derived from a protective protein found in human gastric juice. It is researched for tissue repair, gut healing, tendon and ligament recovery, wound healing, neuroprotection.

GHK-Cu (GHK-Cu (Copper Peptide)) is a Tripeptide-copper complex. Naturally occurring peptide found in human plasma, saliva, and urine; levels decline significantly with age from 200 ng/mL at age 20 to 80 ng/mL by age 60. It is researched for skin rejuvenation, wound healing, anti-aging, hair growth, collagen production, anti-inflammatory effects.

While both are popular research peptides, they work through fundamentally different mechanisms and serve different primary purposes.

How Do BPC-157 and GHK-Cu Work Differently?

BPC-157 mechanism: BPC-157 upregulates growth hormone receptors and promotes angiogenesis (new blood vessel formation) through the FAK-paxillin pathway, which is critical for cell migration and tissue repair. It modulates the nitric oxide system and influences the dopaminergic, serotonergic, and GABAergic neurotransmitter systems. Research also shows it accelerates the formation of reticulin and collagen fibers during wound healing.

GHK-Cu mechanism: GHK-Cu modulates expression of over 4,000 human genes — activating those involved in tissue remodeling, antioxidant defense, and stem cell biology while suppressing genes associated with inflammation and tissue destruction. It promotes collagen and elastin synthesis, attracts immune cells to injury sites, and supports angiogenesis through metalloproteinase regulation.

These distinct mechanisms are why the two peptides are often used for different research goals — or combined to target multiple pathways.

How Do the Dosing Protocols Compare?

BPC-157: 200-500 mcg administered once or twice daily via subcutaneous or intramuscular injection, oral. Half-life: approximately 4 hours (stable form). Cycle: 4-12 weeks.

GHK-Cu: 1-3 mg (injectable), topical formulations vary administered once daily via subcutaneous injection or topical application. Half-life: approximately 2-4 hours. Cycle: 4-12 weeks.

Use our peptide calculator for reconstitution math for either compound.

How Do the Benefits Compare?

BPC-157 benefits: tissue repair, gut healing, tendon and ligament recovery, wound healing, neuroprotection.

GHK-Cu benefits: skin rejuvenation, wound healing, anti-aging, hair growth, collagen production, anti-inflammatory effects.

The overlap in benefits determines whether these peptides compete for the same use case or complement each other in a stack.

How Do the Side Effects Compare?

BPC-157: Generally well-tolerated in research. Minor injection site reactions reported. No significant adverse effects documented in animal studies at therapeutic doses. Long-term human safety data is not yet available.

GHK-Cu: Well-tolerated in research and cosmetic use. Mild injection site reactions possible. Topical use may cause temporary skin redness in sensitive individuals. No systemic toxicity reported.

Can You Stack BPC-157 and GHK-Cu Together?

Many researchers combine BPC-157 and GHK-Cu in stacking protocols. The different mechanisms mean they can potentially provide complementary effects without competing for the same receptors.

Pairs synergistically with TB-500 in the 'Wolverine Stack' for comprehensive tissue repair — BPC-157 handles gut and tendon healing while TB-500 addresses systemic inflammation and cardiac repair. See our stacking guide for general principles.

Which Is Better: BPC-157 or GHK-Cu?

There is no universal answer. BPC-157 may be preferable for researchers focused on tissue repair, while GHK-Cu is stronger for skin rejuvenation.

For the most comprehensive results, many researchers combine both. Review each compound's individual guide for detailed protocols: BPC-157 | GHK-Cu.

Frequently Asked Questions